Sign in

Wilbur Smith III

Independent Director at American Healthcare REIT
Board

About Wilbur H. Smith III

Independent director of American Healthcare REIT, Inc. (AHR) since 2016; age 52; currently serves on the Nominating and Corporate Governance Committee. Founder, CEO and President of Greenlaw Partners, LLC and Greenlaw Management, Inc., with a background spanning acquisitions, operations, and investment redevelopment across >$10 billion of transactions and 220 properties. Education: B.S. in Agriculture (Cal Poly San Luis Obispo) and a master’s in Real Estate Development (USC); licensed California real estate broker. Affiliations: YPO (Orange County Gold Chapter board), Tiger21 (founding Orange County member), USC Lusk Center board, USC Price School Board of Counselors (Vice Chair).

Past Roles

OrganizationRoleTenureCommittees/Impact
Greenlaw Partners, LLCChief Executive Officer, President, FounderFounded March 2003; ongoingPersonally oversees acquisitions, operations, development/redevelopment; >$10.0B in acquisitions/dispositions across 220 properties (office, industrial, retail, multifamily, land)
Greenlaw Management, Inc.FounderFounded March 2003; ongoingCommercial property management leadership
Makar Properties (Newport Beach)Vice President1999–2003Real estate investment/development experience
American Healthcare REITSpecial Committee MemberOct 2020–Oct 2021Served during strategic board processes

External Roles

OrganizationRoleTenureNotes
Young Presidents’ Organization (YPO)Board member, Orange County Gold ChapterCurrentExecutive network involvement
Tiger21Founding member, Orange County ChapterCurrentInvestor peer network
USC Lusk Center for Real EstateExecutive BoardCurrentReal estate academic engagement
USC Price SchoolBoard of Counselors, Vice ChairCurrentAcademic governance role
California Dept. of Real EstateLicensed BrokerCurrentProfessional licensure

Board Governance

  • Independence: AHR’s Board has determined Mr. Smith is independent under NYSE standards; he is one of six independent directors on a nine-member Board.
  • Committee assignments: Member, Nominating & Corporate Governance Committee (NCGC) since October 2021; NCGC comprised of Flornes (Chair), Smith, Richardson; held three meetings in 2024.
  • Attendance: Board held nine meetings in 2024; each incumbent director attended at least 75% of Board and applicable committee meetings.
  • Leadership structure: Separate Chair and CEO; non-management directors hold executive sessions at least annually; there is no lead independent director.
  • Conflicts oversight: NCGC oversees conflicts and related-party transactions; AHR has a formal Related Party Transactions Policy requiring NCGC approval/ratification.

Fixed Compensation

ComponentAmountNotes
Cash fees (2024)$85,000Fees earned/paid in cash for service as non-employee director
Committee cash schedule (reference)Audit Chair: $20,000; Audit Member: $5,000; Compensation Chair: $12,500; NCGC Chair: $12,500; Lead Independent Director: $100,000Mr. Smith is an NCGC member (not Chair); schedule illustrates incremental chair/member fees
ReimbursementsOut-of-pocket expenses reimbursed monthlyStandard director practice; no other benefits

Performance Compensation

Equity AwardShares/ValueGrant DateVestingNotes
Listing Equity Award (RS)7,407 shares; $192,159 grant-date valueFeb 9, 202425% annually on each of the first four anniversaries of grant, subject to continued serviceSame vesting terms as employee Listing Equity Awards; directors received restricted stock (time-based, not performance-conditioned)

No director-specific performance metrics (TSR, FFO, etc.) apply to director equity awards; these are time-based restricted shares.

Other Directorships & Interlocks

  • Other public company boards: None disclosed for Mr. Smith in AHR’s 2025 DEF 14A biography.
  • Private/industry boards: YPO, Tiger21, USC Lusk Center, USC Price School Board of Counselors (Vice Chair).
  • Interlocks: No shared directorships with AHR competitors/suppliers/customers disclosed.

Expertise & Qualifications

  • Real estate operations, acquisitions, and capital markets expertise; oversight of large, multi-asset portfolios and joint ventures with leading global institutions.
  • Academic and industry engagement (USC real estate boards); licensed broker; senior leadership roles in development and property management.
  • Board contribution: Enhances investment strategies and operational execution; aligns with AHR’s healthcare real estate focus.

Equity Ownership

HolderBeneficial Ownership (Shares)% of OutstandingOP UnitsPledge StatusNonvested Restricted Shares (as of 12/31/24)
Wilbur H. Smith III29,337<1.0%0None of the above shares pledged11,017
  • Hedging/Pledging policy: Directors are prohibited from entering hedging or pledging transactions involving AHR securities.
  • Ownership guidelines: AHR Corporate Governance Guidelines set minimum stock ownership requirements for directors and officers (specific multiples not disclosed in proxy).

Governance Assessment

  • Board effectiveness: Smith’s deep operating and development background in commercial real estate (>$10B transactions; 220 properties) adds practical investment discipline and asset optimization expertise to AHR’s board, benefitting capital allocation and portfolio strategy.
  • Independence and engagement: Independent status, active committee service (NCGC), and minimum attendance threshold achieved across Board and committee meetings support investor confidence in governance rigor.
  • Alignment: Time-based restricted stock grants and beneficial ownership provide direct economic alignment; hedging/pledging prohibitions and ownership guidelines further strengthen alignment with shareholders.
  • Conflicts: Smith leads private real estate firms (Greenlaw). AHR’s NCGC formally oversees conflicts and related-party transactions, and no transactions with Greenlaw or family members are disclosed; directors must recuse from any conflicted votes. This mitigates perceived conflict risk.
  • RED FLAGS: None observed in the proxy related to pledging, related-party transactions, attendance, or director-specific pay anomalies.